You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動 | 腦再生科技盤前大漲64% 昨日一度暴漲4.3倍 年內累漲64208%
腦再生科技(RGC.US)盤前一度大漲64.65%至98.79美元。該股昨日盤中一度暴漲434%至83.6美元,股價創歷史新高,年內飆升642倍(漲幅64207.69%)。最終收漲283.13%報60美元,市值逼近300億美元。腦再生科技是一家早期生物科學公司,當下備受矚目的腦機接口技術引爆股價。今年5月9日,腦再生科技宣佈其新一代神經調控芯片通過FDA臨牀試驗審批,將與全球頂尖醫療機構梅奧診所合作,開展帕金森病治療研究。今年6月2日,該公司宣佈進行38比1的股票拆分,股票分配定於6月13日,拆分後的交易定於6月16日(即昨日,本週一)進行。流通股規模擴大後,散戶投資者蜂擁入場,但流通股數量極少,推升股價飆漲。值得注意的是,截至2024年6月末,腦再生科技尚未從銷售任何產品中獲得任何收入,2021至2024財年,公司營收爲0,且其核心療法需通過FDA三期臨牀,失敗概率高達80%(行業均值)。腦再生科技在2024財年財報中表示:“可能永遠無法盈利”“持續經營存在不確定性”。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account